speb/financial-data huggingface dataset:
UTI balance_sheet (annual, 2025-09-30) — Other Current Liabilities: 13670000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 13670000.00
UTI balance_sheet (annual, 2025-09-30) — Other Equity Adjustments: 912000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 912000.00
UTI income_statement (annual, 2025-09-30) — Other Gand A: 81184000.00
UTI income_statement (quarterly, 2025-09-30) — Other Gand A: 22284000.00
UTI income_statement (annual, 2025-09-30) — Other Income Expense: 265000.00
UTI income_statement (quarterly, 2025-09-30) — Other Income Expense: 142000.00
UTI balance_sheet (annual, 2025-09-30) — Other Intangible Assets: 17352000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 17352000.00
UTI cash_flow (annual, 2025-09-30) — Other Non Cash Items: 1915000.00
UTI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 844000.00
UTI balance_sheet (annual, 2025-09-30) — Other Non Current Assets: 23591000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 23591000.00
UTI balance_sheet (annual, 2025-09-30) — Other Non Current Liabilities: 5142000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 5142000.00
UTI income_statement (annual, 2025-09-30) — Other Non Operating Income Expenses: 265000.00
UTI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 142000.00
UTI balance_sheet (annual, 2025-09-30) — Other Properties: 291994000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Properties: 291994000.00
UTI balance_sheet (annual, 2025-09-30) — Other Receivables: 5111000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Receivables: 5111000.00
UTI balance_sheet (annual, 2025-09-30) — Other Short Term Investments: 41784000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 41784000.00
UTI income_statement (annual, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
UTI income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
UTI balance_sheet (annual, 2025-09-30) — Payables: 39115000.00
UTI balance_sheet (quarterly, 2025-09-30) — Payables: 39115000.00
UTI balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 60644000.00
UTI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 60644000.00
UTI balance_sheet (annual, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 44000000.00
UTI balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 44000000.00
UTI balance_sheet (annual, 2025-09-30) — Preferred Stock: 0.00
UTI balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
UTI cash_flow (annual, 2025-09-30) — Preferred Stock Dividend Paid: 0.00
UTI cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: 0.00
UTI cash_flow (annual, 2025-09-30) — Preferred Stock Payments: 0.00
UTI cash_flow (quarterly, 2025-09-30) — Preferred Stock Payments: 0.00
UTI balance_sheet (annual, 2025-09-30) — Prepaid Assets: 12526000.00
UTI balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 12526000.00
UTI income_statement (annual, 2025-09-30) — Pretax Income: 84274000.00
UTI income_statement (quarterly, 2025-09-30) — Pretax Income: 25559000.00
UTI cash_flow (annual, 2025-09-30) — Proceeds From Stock Option Exercised: 659000.00
UTI cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
UTI balance_sheet (annual, 2025-09-30) — Properties: 0.00
UTI balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
UTI cash_flow (annual, 2025-09-30) — Provisionand Write Offof Assets: 22144000.00
UTI cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 7081000.00
UTI cash_flow (annual, 2025-09-30) — Purchase Of Business: 0.00
UTI cash_flow (annual, 2025-09-30) — Purchase Of Investment: -68371000.00
UTI cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -13723000.00
UTI cash_flow (annual, 2025-09-30) — Purchase Of PPE: -41978000.00
UTI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -16479000.00
UTI balance_sheet (annual, 2025-09-30) — Receivables: 52675000.00
UTI balance_sheet (quarterly, 2025-09-30) — Receivables: 52675000.00
UTI balance_sheet (annual, 2025-09-30) — Receivables Adjustments Allowances: -22206000.00
UTI balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -22206000.00
UTI income_statement (annual, 2025-09-30) — Reconciled Cost Of Revenue: 420491000.00
UTI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 112258000.00
UTI income_statement (annual, 2025-09-30) — Reconciled Depreciation: 56785000.00
UTI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 14841000.00
UTI income_statement (annual, 2025-09-30) — Rent Expense Supplemental: 55949000.00
UTI income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 15325000.00
UTI cash_flow (annual, 2025-09-30) — Repayment Of Debt: -64697000.00
UTI cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -6687000.00
UTI cash_flow (annual, 2025-09-30) — Repurchase Of Capital Stock: 0.00
UTI cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
UTI balance_sheet (annual, 2025-09-30) — Restricted Cash: 6769000.00
UTI balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 6769000.00
UTI balance_sheet (annual, 2025-09-30) — Retained Earnings: 101527000.00
UTI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 101527000.00
UTI income_statement (annual, 2025-09-30) — Salaries And Wages: 161882000.00
UTI income_statement (quarterly, 2025-09-30) — Salaries And Wages: 42202000.00
UTI cash_flow (annual, 2025-09-30) — Sale Of Investment: 22301000.00
UTI cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 20427000.00
UTI income_statement (annual, 2025-09-30) — Selling And Marketing Expense: 88590000.00
UTI income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 20712000.00
UTI income_statement (annual, 2025-09-30) — Selling General And Administration: 331656000.00
UTI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 85198000.00
UTI balance_sheet (annual, 2025-09-30) — Share Issued: 54512000.00
UTI balance_sheet (quarterly, 2025-09-30) — Share Issued: 54512000.00
UTI cash_flow (annual, 2025-09-30) — Short Term Debt Issuance: 26000000.00
UTI cash_flow (annual, 2025-09-30) — Stock Based Compensation: 9151000.00
UTI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2749000.00
UTI balance_sheet (annual, 2025-09-30) — Stockholders Equity: 328110000.00
UTI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 328110000.00
UTI balance_sheet (annual, 2025-09-30) — Tangible Book Value: 282299000.00
UTI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 282299000.00
UTI income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (annual, 2025-09-30) — Tax Provision: 21256000.00
UTI income_statement (quarterly, 2025-09-30) — Tax Provision: 6803000.00
UTI income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.25
UTI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
UTI balance_sheet (annual, 2025-09-30) — Taxes Receivable: 585000.00
UTI balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 585000.00
UTI balance_sheet (annual, 2025-09-30) — Total Assets: 826139000.00
UTI balance_sheet (quarterly, 2025-09-30) — Total Assets: 826139000.00
UTI balance_sheet (annual, 2025-09-30) — Total Capitalization: 412344000.00
UTI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 412344000.00
UTI balance_sheet (annual, 2025-09-30) — Total Debt: 278904000.00
UTI balance_sheet (quarterly, 2025-09-30) — Total Debt: 278904000.00
UTI balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 328110000.00
UTI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 328110000.00
UTI income_statement (annual, 2025-09-30) — Total Expenses: 752147000.00
UTI income_statement (quarterly, 2025-09-30) — Total Expenses: 197456000.00
UTI balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 498029000.00
UTI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 498029000.00
UTI balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 579507000.00
UTI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 579507000.00
UTI balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 268358000.00
UTI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 268358000.00
UTI income_statement (annual, 2025-09-30) — Total Operating Income As Reported: 83469000.00
UTI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 24986000.00
UTI balance_sheet (annual, 2025-09-30) — Treasury Shares Number: 82000.00
UTI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 82000.00
UTI balance_sheet (annual, 2025-09-30) — Treasury Stock: 365000.00
UTI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 365000.00
UTI balance_sheet (annual, 2025-09-30) — Working Capital: 16961000.00
UTI balance_sheet (quarterly, 2025-09-30) — Working Capital: 16961000.00
UTI income_statement (quarterly, 2025-12-31) — +Operating Expense: 94709000.00
UTI income_statement (quarterly, 2025-12-31) — +Total Revenue: 220844000.00
UTI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 29979000.00
UTI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 44986000.00
UTI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -194331000.00
UTI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 221098000.00
UTI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 54570000.00
UTI income_statement (quarterly, 2025-12-31) — Basic EPS: 0.24
UTI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 134130000.00
UTI balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 168368000.00
UTI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -22680000.00
UTI cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -438000.00
UTI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 188149000.00
UTI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5000.00
UTI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 93567000.00
UTI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 162811000.00
UTI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 6809000.00
UTI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -46556000.00
UTI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3084000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -12113000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 4613000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -5552000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -1218000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Payable: -12113000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -12113000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -12418000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Receivables: -10934000.00
UTI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -37622000.00
UTI cash_flow (quarterly, 2025-12-31) — Changes In Cash: -36663000.00
UTI balance_sheet (quarterly, 2025-12-31) — Common Stock: 5000.00
UTI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 335909000.00
UTI balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 52977000.00
UTI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 110448000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 26454000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Assets: 248657000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 18582000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Debt: 2904000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 21486000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 88580000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 88580000.00
UTI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 217865000.00
UTI cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2291000.00
UTI cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2291000.00
UTI cash_flow (quarterly, 2025-12-31) — Depreciation: 15274000.00
UTI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 15274000.00
UTI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 15274000.00
UTI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 55744000.00
UTI income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.23
UTI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 12827000.00
UTI income_statement (quarterly, 2025-12-31) — EBIT: 17183000.00
UTI income_statement (quarterly, 2025-12-31) — EBITDA: 32457000.00
UTI cash_flow (quarterly, 2025-12-31) — End Cash Position: 97467000.00
UTI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 6809000.00
UTI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -19596000.00
UTI cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -95000.00
UTI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 817000.00
UTI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 69503000.00
UTI balance_sheet (quarterly, 2025-12-31) — Goodwill: 28459000.00
UTI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 49483000.00
UTI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 668275000.00
UTI income_statement (quarterly, 2025-12-31) — Gross Profit: 110396000.00
UTI cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 585000.00
UTI income_statement (quarterly, 2025-12-31) — Interest Expense: 971000.00
UTI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 971000.00
UTI income_statement (quarterly, 2025-12-31) — Interest Income: 1546000.00
UTI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1546000.00
UTI cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 997000.00
UTI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 437328000.00
UTI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -46556000.00
UTI cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 35000000.00
UTI balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 25601000.00
UTI balance_sheet (quarterly, 2025-12-31) — Leases: 102428000.00
UTI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 169567000.00
UTI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 98515000.00
UTI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 268082000.00
UTI cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -20703000.00
UTI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 38228000.00
UTI balance_sheet (quarterly, 2025-12-31) — Net Debt: 7852000.00
UTI income_statement (quarterly, 2025-12-31) — Net Income: 12827000.00
UTI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 12827000.00
UTI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 12827000.00
UTI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 12827000.00
UTI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 12827000.00
UTI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 12827000.00
UTI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 12827000.00
UTI income_statement (quarterly, 2025-12-31) — Net Interest Income: 575000.00
UTI cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -23876000.00
UTI cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 14297000.00
UTI cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -20703000.00
UTI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 575000.00
UTI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -7488000.00
UTI balance_sheet (quarterly, 2025-12-31) — Net PPE: 473944000.00
UTI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -22242000.00
UTI cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 35000000.00
UTI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 286426000.00
UTI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1960000.00
UTI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 4135000.00
UTI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1960000.00
UTI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 4135000.00
UTI balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 44668000.00
UTI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 32457000.00
UTI income_statement (quarterly, 2025-12-31) — Normalized Income: 12827000.00
UTI balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 6698000.00
UTI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3084000.00
UTI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -95000.00
UTI income_statement (quarterly, 2025-12-31) — Operating Income: 15687000.00
UTI income_statement (quarterly, 2025-12-31) — Operating Revenue: 220844000.00
UTI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 55014000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6427000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 2904000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 14574000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 817000.00
UTI income_statement (quarterly, 2025-12-31) — Other Gand A: 25256000.00
UTI income_statement (quarterly, 2025-12-31) — Other Income Expense: -50000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 21024000.00
UTI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 69000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 15249000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 7970000.00
UTI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -50000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Properties: 280673000.00
UTI balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 69244000.00
UTI balance_sheet (quarterly, 2025-12-31) — Payables: 29979000.00
UTI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 56433000.00
UTI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 36792000.00
UTI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 23835000.00
UTI income_statement (quarterly, 2025-12-31) — Pretax Income: 16212000.00
UTI cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
UTI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
UTI cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 7785000.00
UTI cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -33705000.00
UTI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -22242000.00
UTI balance_sheet (quarterly, 2025-12-31) — Receivables: 51684000.00
UTI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 110448000.00
UTI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 15274000.00
UTI income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 14602000.00
UTI cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -20703000.00
UTI balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 3900000.00
UTI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 114354000.00
UTI income_statement (quarterly, 2025-12-31) — Salaries And Wages: 44247000.00
UTI cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 9829000.00
UTI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 25206000.00
UTI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 94709000.00
UTI balance_sheet (quarterly, 2025-12-31) — Share Issued: 55096000.00
UTI cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 35000000.00
UTI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2555000.00
UTI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 335909000.00
UTI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 286426000.00
UTI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (quarterly, 2025-12-31) — Tax Provision: 3385000.00
UTI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
UTI balance_sheet (quarterly, 2025-12-31) — Total Assets: 833961000.00
UTI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 434424000.00
UTI balance_sheet (quarterly, 2025-12-31) — Total Debt: 289568000.00
UTI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 335909000.00
UTI income_statement (quarterly, 2025-12-31) — Total Expenses: 205157000.00
UTI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 498052000.00
UTI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 585304000.00
UTI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 280187000.00
UTI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 15687000.00
UTI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 82000.00
UTI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 365000.00
UTI balance_sheet (quarterly, 2025-12-31) — Working Capital: 30792000.00
UTI income_statement (quarterly, 2026-03-31) — +Operating Expense: 103634000.00
UTI income_statement (quarterly, 2026-03-31) — +Total Revenue: 221402000.00
UTI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 42604000.00
UTI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 44619000.00
UTI balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -200573000.00
UTI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 224752000.00
UTI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 55033000.00
UTI income_statement (quarterly, 2026-03-31) — Basic EPS: 0.01
UTI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 97467000.00
UTI balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 168775000.00
UTI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -31234000.00
UTI cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -815000.00
UTI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 185484000.00
UTI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6000.00
UTI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 87233000.00
UTI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 161983000.00
UTI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 29045000.00
UTI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -36890000.00
UTI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 3985000.00
UTI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -1704000.00
UTI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -5172000.00
UTI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -24627000.00
UTI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 11187000.00
UTI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 4358000.00
UTI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -7512000.00
UTI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -23470000.00
UTI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3860000.00
UTI balance_sheet (quarterly, 2026-03-31) — Common Stock: 6000.00
UTI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 339905000.00
UTI balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 59147000.00
UTI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 117429000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 28269000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Assets: 243785000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 20704000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Debt: 2953000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 23657000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 74033000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 74033000.00
UTI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 207932000.00
UTI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -755000.00
UTI cash_flow (quarterly, 2026-03-31) — Deferred Tax: -755000.00
UTI cash_flow (quarterly, 2026-03-31) — Depreciation: 15632000.00
UTI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 15632000.00
UTI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 15632000.00
UTI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 55730000.00
UTI income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.01
UTI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 433000.00
UTI income_statement (quarterly, 2026-03-31) — EBIT: 1376000.00
UTI income_statement (quarterly, 2026-03-31) — EBITDA: 17008000.00
UTI cash_flow (quarterly, 2026-03-31) — End Cash Position: 93607000.00
UTI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 29045000.00
UTI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -27249000.00
UTI cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 103000.00
UTI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 725000.00
UTI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 72179000.00
UTI balance_sheet (quarterly, 2026-03-31) — Goodwill: 28459000.00
UTI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 49866000.00
UTI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 694265000.00
UTI income_statement (quarterly, 2026-03-31) — Gross Profit: 103973000.00
UTI cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 10954000.00
UTI income_statement (quarterly, 2026-03-31) — Interest Expense: 993000.00
UTI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 993000.00
UTI income_statement (quarterly, 2026-03-31) — Interest Income: 1060000.00
UTI income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1060000.00
UTI cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1023000.00
UTI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 470639000.00
UTI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -36890000.00
UTI cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 65000000.00
UTI balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 25601000.00
UTI balance_sheet (quarterly, 2026-03-31) — Leases: 116222000.00
UTI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 164780000.00
UTI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 127781000.00
UTI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 292561000.00
UTI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -35708000.00
UTI balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 41068000.00
UTI balance_sheet (quarterly, 2026-03-31) — Net Debt: 43501000.00
UTI income_statement (quarterly, 2026-03-31) — Net Income: 433000.00
UTI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 433000.00
UTI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 433000.00
UTI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 433000.00
UTI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 433000.00
UTI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 433000.00
UTI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 433000.00
UTI income_statement (quarterly, 2026-03-31) — Net Interest Income: 67000.00
UTI cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -5692000.00
UTI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 29292000.00
UTI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 64292000.00
UTI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 67000.00
UTI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -247000.00
UTI balance_sheet (quarterly, 2026-03-31) — Net PPE: 493692000.00
UTI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -30419000.00
UTI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 290039000.00
UTI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 2744000.00
UTI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 4144000.00
UTI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 2744000.00
UTI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4144000.00
UTI balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 45205000.00
UTI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 17008000.00
UTI income_statement (quarterly, 2026-03-31) — Normalized Income: 433000.00
UTI balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 6735000.00
UTI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3985000.00
UTI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 103000.00
UTI income_statement (quarterly, 2026-03-31) — Operating Income: 339000.00
UTI income_statement (quarterly, 2026-03-31) — Operating Revenue: 221402000.00
UTI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 55061000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 5568000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2953000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 3883000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 725000.00
UTI income_statement (quarterly, 2026-03-31) — Other Gand A: 25973000.00
UTI income_statement (quarterly, 2026-03-31) — Other Income Expense: -23000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 21407000.00
UTI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 694000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 16893000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 7643000.00
UTI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -23000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Properties: 283452000.00
UTI balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 74750000.00
UTI balance_sheet (quarterly, 2026-03-31) — Payables: 42604000.00
UTI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 70873000.00
UTI balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 35486000.00
UTI balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 18506000.00
UTI income_statement (quarterly, 2026-03-31) — Pretax Income: 383000.00
UTI cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
UTI balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
UTI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -19531000.00
UTI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -30419000.00
UTI balance_sheet (quarterly, 2026-03-31) — Receivables: 51354000.00
UTI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 117429000.00
UTI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 15632000.00
UTI income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 14942000.00
UTI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -35708000.00
UTI balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 6374000.00
UTI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 114787000.00
UTI income_statement (quarterly, 2026-03-31) — Salaries And Wages: 46206000.00
UTI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 13839000.00
UTI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 31455000.00
UTI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 103634000.00
UTI balance_sheet (quarterly, 2026-03-31) — Share Issued: 55143000.00
UTI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3901000.00
UTI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 339905000.00
UTI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 290039000.00
UTI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (quarterly, 2026-03-31) — Tax Provision: -50000.00
UTI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
UTI balance_sheet (quarterly, 2026-03-31) — Total Assets: 852185000.00
UTI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 467686000.00
UTI balance_sheet (quarterly, 2026-03-31) — Total Debt: 316218000.00
UTI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 339905000.00
UTI income_statement (quarterly, 2026-03-31) — Total Expenses: 221063000.00
UTI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 512280000.00
UTI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 608400000.00
UTI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 304348000.00
UTI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 339000.00
UTI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 82000.00
UTI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 365000.00
UTI balance_sheet (quarterly, 2026-03-31) — Working Capital: 35853000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 476800000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Amortization: 57400000.00
UTIAMC.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 57400000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 126800000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Basic EPS: 42.12
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 899400000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 1745900000.00
UTIAMC.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -2155400000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 335000000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 238400000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 127300000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Diluted EPS: 41.96
UTIAMC.NS cash_flow (annual, 2022-03-31) — Dividend Received Cfo: 8100000.00
UTIAMC.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: -8100000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 11927600000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 364700000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 0.00
UTIAMC.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 100000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 282700000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 181100000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Other Special Charges: 900000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 19200000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 19200000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 32087800000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 198000000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 562700000.00
UTIAMC.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 800000.00
UTIAMC.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
UTIAMC.NS income_statement (annual, 2023-03-31) — +Operating Expense: 3125500000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — +Total Revenue: 11313700000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 506200000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 871300000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -631400000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 501700000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Amortization: 65800000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 65800000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1270900000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 126900000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Basic EPS: 34.45
UTIAMC.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1734200000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 2697200000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1089400000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 1269800000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2094500000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 21875000000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -2666200000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 2094500000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 423600000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -479800000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Change In Payable: 178100000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -111700000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -260500000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 360300000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Common Stock: 1269800000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -2666200000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 38678400000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 25500000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Common Stock Payments: -300000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 64800000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3815400000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Current Assets: 23607400000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 113200000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1705600000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 101800000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Depreciation: 333600000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 399400000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 399400000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 333600000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 127000000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Diluted EPS: 34.44
UTIAMC.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 4373600000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — EBIT: 5958400000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — EBITDA: 6357800000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — End Cash Position: 2094500000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 13014200000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -2668900000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 2864900000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -987900000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 1600000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 396500000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 39500000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 4177500000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Gross Profit: 7498300000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Interest Expense: 102200000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 102200000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Interest Income: 237300000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 237300000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -95500000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 236800000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 38678400000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -925100000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 91700000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 14285100000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 25500000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 5800000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 549000000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Minority Interests: -23200000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 25500000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 428200000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Income: 4373600000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 4373600000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 4396800000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 0.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 4373600000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 4373600000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 5856200000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 4396800000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Interest Income: 135100000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -773000000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 135100000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -300000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 130200000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3546100000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -519100000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 38638900000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 165000000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 5371500000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Normalized Income: 3633085960.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 3954300000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Operating Income: 4372800000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Operating Revenue: 11313700000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 126983695.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 453000000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 146100000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 778700000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 39500000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -264800000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 57300000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 33400000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 258300000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1235900000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Payable: 774700000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Properties: 931300000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 29400000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 19780500000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Other Special Charges: 1600000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Payables: 1280900000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Pretax Income: 5856200000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1760900000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1089400000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3815400000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 399400000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 21000000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 21000000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -300000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 0.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 33800900000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 987900000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 570300000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 219900000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 616400000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Share Issued: 126983695.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Special Income Charges: -1600000.00
UTIAMC.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 200800000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 38678400000.00
UTIAMC.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 38638900000.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 245785960.00
UTIAMC.NS income_statement (annual, 2023-03-31) — Tax Provision: 1459400000.00